Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›NICE Talks›Changing the course: the NHS's first treatment to delay type 1 diabetes

Science & Medicine

Changing the course: the NHS's first treatment to delay type 1 diabetes

NICE Talks by NICE Talks

Jun 30, 202600:10:40Science & Medicine

NICE has recommended teplizumab for NHS use — the first treatment to delay the onset of symptomatic type 1 diabetes by an average of nearly three years. In this episode, we speak to Lucy Chambers, Head of Research Impact...

Related Episodes

Continue listening to more episodes from NICE Talks.

Second Chances: How new technology is transforming organ transplants

Aug 25, 2026 - 00:13:25

In this episode, we explore how new machine perfusion technology is changing the landscape of organ trans...

PMOS: how the new draft NICE guideline could transform diagnosis and care

Jul 29, 2026 - 00:13:16

In this episode we explore the draft NICE guideline for PMOS (formerly known as PCOS), out for public con...

Treating babies at home with oral antibiotics

May 27, 2026 - 00:13:50

In this episode we discuss the recent changes to the NICE guideline for neonatal infections, that mean ne...

Endometriosis fertility care and gynaecological cancer guidance

Apr 29, 2026 - 00:14:51

In this episode of NICE Talks, we're covering some of the most significant guidance updates of the year s...

Backing the healthtech that changes lives

Mar 31, 2026 - 00:13:00

When the right technology reaches the right patient, lives change. In this episode of NICE Talks, we hear...

How NICE guidance is accelerating access to innovative migraine treatments

Feb 26, 2026 - 00:08:13

In this episode, we discuss two innovative migraine treatments recommended by NICE. We explore the rapid...

The asthma guideline – one year on

Jan 29, 2026 - 00:14:33

In this episode of NICE Talks, we learn the impact of the joint asthma guideline published in November 20...

Reviewing 2025: Producing faster rigorous guidance to make an impact on patient's lives

Dec 31, 2025 - 00:17:10

We look back on the guidance we've produced in 2025. We're joined by director of medicines evaluation Hel...